Key Findings

• New Jersey becomes the first state to implement a comprehensive regulatory framework governing embryo and egg storage facilities.
• The law mandates stringent safety and emergency systems, including backup power, monitoring alarms, and clear tissue disposition protocols.

In a landmark move to protect families pursuing fertility treatment, the New Jersey Department of Health has adopted the nation's first comprehensive state regulatory framework governing the storage and cryopreservation of human eggs and embryos. The adoption, announced on December 15, 2025, establishes unprecedented standards for licensure and oversight of reproductive tissue storage facilities across the state.

The regulatory action addresses a critical gap in oversight. While assisted reproductive technology (ART) has surged in recent years, with New Jersey fertility clinics performing nearly 13,000 ART procedures in 2022 alone, resulting in more than 5,500 live birth deliveries, according to the Centers for Disease Control and Prevention, reproductive tissue storage has long operated under a fragmented system of federal agency oversight and voluntary professional standards. New Jersey sets embryo storage regulations to fill this void and establish a uniform safety benchmark that other states may follow.

Protecting Families, Ensuring Safety

“Today, we are setting a national standard for safe embryo storage. Undergoing fertility services can be an emotional and life-altering process for New Jerseyans trying to start a family. The last thing patients undergoing fertility services should have to worry about is whether their eggs and embryos are stored correctly,” said Governor Phil Murphy. “By setting clear regulations, we are holding embryo storage facilities in New Jersey to a higher standard and ensuring patients focus on what matters most in their pursuit of parenthood.”

“The decision to pursue fertility treatment is deeply personal, and New Jerseyans deserve to know that the facilities storing their eggs and embryos meet rigorous standards,” said Acting Health Commissioner Jeff Brown. “With these rules, New Jersey is setting a national benchmark for protecting people hoping to start or grow their families as they navigate one of the most significant and complicated periods in their lives."

Scope and Applicability

The regulatory framework applies to any facility that stores or cryopreserves human eggs or embryos, including reproductive laboratories, in-vitro fertilization clinics, reproductive medicine practices, hospitals, and other healthcare entities offering these services.

Stringent Operational and Safety Requirements

The regulations establish comprehensive standards designed to prevent the catastrophic equipment failures and storage system breakdowns that have affected facilities in other states. Key requirements include:

Physical Safety and Infrastructure

• Backup power systems for critical storage equipment
• Oxygen sensors in rooms where liquid nitrogen is used
• Remote alarm systems on cryogenic storage equipment

Accreditation and Registration

Facilities that store human eggs and embryos must apply for state licensure. With limited exceptions, licensed healthcare providers storing fresh eggs or embryos onsite for immediate use in ART procedures, all facilities must obtain accreditation from either the College of American Pathologists' Reproductive Accreditation Program or the Joint Commission on Accreditation of Healthcare Organizations' Laboratory or Office-Based Surgery Accreditation Programs. Those required to register with the U.S. Food and Drug Administration as a Human Cell and Tissue (HCT/P) Establishment must demonstrate current registration.

Operational Governance

• Annual licensure and renewal requirements
• Mandatory written policies addressing reproductive tissue disposition in circumstances including facility closure, client death or incapacity, and nonpayment of storage fees
• Comprehensive recordkeeping requirements, with records maintained for at least 10 years after reproductive tissue is released for use
• Reporting requirements for equipment failures, errors, and emergencies that could affect stored reproductive tissue
  

Expert Input and Regulatory Development

The regulations were developed with input from an advisory panel of specialists spanning embryology, biobanking management, reproductive medicine, laboratory operations, and reproductive rights. This multidisciplinary approach ensures that the framework reflects current best practices and protects reproductive autonomy alongside safety.

Implementation Timeline

The rules became effective upon publication in the December 15, 2025, New Jersey Register. To facilitate a smooth transition, the Department has established a practical implementation schedule:

• January 15, 2026: Deadline for currently operating embryo storage facilities to provide written notice of intent to apply for licensure
• February 13, 2026: Application submission deadline
• Provisional Licensure: Facilities that are accredited, in good standing, and timely provide the requisite written notice will be deemed to have provisional licensure to continue operations while applications are under review

Setting a National Standard

By establishing the first comprehensive state-level regulatory framework for embryo storage facilities, New Jersey sets embryo storage regulations as a model that addresses longstanding gaps in patient protection. The framework aims to give individuals and couples utilizing assisted reproductive technology greater confidence in the integrity of stored reproductive tissue and its availability for their future use or benefit, while simultaneously decreasing the probability of avoidable equipment failures that have historically resulted in irreversible losses.